New research published in The BMJ indicates that weight lost through blockbuster GLP-1 drugs like Ozempic and Wegovy is regained if patients stop taking them, similar to how cholesterol levels rebound after discontinuing statins. These drugs, initially for diabetes, are now widely used for weight loss and show potential benefits for cardiovascular health and other conditions. Despite their growing popularity and immense market potential, particularly in India, the long-term effects and sustainability of weight loss after cessation remain a key concern for users and healthcare providers.